‌

US Patent 11773090 Pharmaceutical compounds

Patent 11773090 was granted and assigned to Heptares Therapeutics on October, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Heptares Therapeutics

Current Assignee

Heptares Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Giles Albert Brown

Benjamin Gerald Tehan

Barry John Teobald

Date of Patent

October 3, 2023

Patent Application Number

17024085

Date Filed

September 17, 2020

Patent Citations

US Patent 9067951 Process and intermediates for the production of CCR2 antagonists

US Patent 9187451 Muscarinic M1 receptor agonists

US Patent 9266857 Bicyclic AZA compounds as muscarinic M1 receptor agonists

US Patent 9573929 Muscarinic M1 receptor agonists

US Patent 9593106 Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonists

US Patent 9669013 Bicyclic aza compounds as muscarinic M1 receptor agonists

US Patent 9670183 Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists

US Patent 9758506 Muscarinic agonists

...

Patent Citations Received

US Patent 12024499 Muscarinic agonists

0

US Patent 11945801 Bicyclic aza compounds as muscarinic M

0

Patent Primary Examiner

Zinna Northington Davis

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11773090 Pharmaceutical compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.